SETIPIPRANT
UNII BHF20LA2GM

Substance Identification & Data

This profile provides standardized clinical and technical data for Setipiprant, uniquely identified by the FDA Unique Ingredient Identifier (UNII) BHF20LA2GM.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 866460-33-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

BHF20LA2GM

CAS Registry Number

866460-33-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SETIPIPRANT

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C24H19FN2O3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

IHAXLPDVOWLUOS-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C152348

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

49843471

Unique identification number in the NCBI database of chemical substances.

INN ID

9330

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

ZZ-22

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

Fc1cc2c3CN(CCc3n(c2cc1)CC(=O)O)C(=O)c4c5c(ccc4)cccc5

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Setipiprant. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.